Catch up on current trends before heading to San Antonio.
Why not enrich your experience by watching recent AAPS webinars related to these two end-to-end hot topics? Brush up on these topics before you go to increase your understanding, open avenues of discussion, and bolster conversations with prospective employers or collaborators.This year’s AAPS PharmSci 360 in San Antonio will feature two end-to-end hot topics. These two topics will have daily symposia developed for each of PharmSci 360’s five scientific tracks, giving attendees a wide breadth of science throughout the drug development process.
Take advantage of your AAPS membership and select from these on-demand webinars:
Nucleic Acid-Based Therapeutics:
- Gene therapy: Bioanalytical support and strategies—Learn about current practices in method platform selection, method design, and optimization in support of gene therapy modalities, and gain an overview of method validation and relevant guidelines.
- The Role of Biomarkers in Supporting Personalized Medicine Efforts—Learn how to define biomarkers and their use in drug development, correlate genetic polymorphism and genetic constituents of patients with biomarkers, describe diagnostic biomarkers and their application in drug development, and identify subpopulations with prognostic biomarkers.
- The Role of CDER Genomics and Targeted Therapy Group in Maximizing the Impact of Individualized Therapy—Learn how to identify the Food and Drug Administration’s role in the precision medicine initiative, use the streamlined regulatory validation mechanism for targeted therapies, implement the findings of the Drug Development Tool Qualification Program, and list advancements initiated by Genomics and Targeted Therapy Group in the Office of Clinical Pharmacology for precision medicine.
The Journey to Developing Tissue- and Organ-Specific Therapies:
- Personalized Medicine in Neurological Diseases—Learn about the current landscape and prospects for treatment of neurodegenerative, neuropsychiatric, and other neurological diseases; explore the genetic architecture of common diseases and application to the development of new therapies, biomarkers, or patient stratifications; and analyze the feasibility of a personalized medicine approach and what key information or infrastructure may be needed.
- Nasally Administered Drug Products: Clinically Relevant In-Vitro Tests—Learn about current in-vitro testing methods for nasal spray products and in-vitro methods to realistically evaluate nasal spray products using a nasal airway physical model. Also, you will gain an understanding of the effect on regional nasal spray drug deposition in a realistic airway model and how a realistic test method of nasal drug delivery can be employed to evaluate a novel nasal ciprofloxacin nanocomposite powder. Additionally, you will learn about the incorporation of in-vivo cell monolayers into the realistic nasal airway model to investigate drug transepithelial transport after realistic nasal deposition.
- Metered Dose Inhalers 101—Understand and review a broad technical foundation on the basics of metered dose inhaler science, and gain insight into historical perspectives on metered dose inhalers as well as emerging technologies to deliver drug into the lung or systemically.
VISIT
Browse these and other AAPS webinars to see the full spectrum of topics for both upcoming and archived webinars. Take advantage of your member benefit and make the most of your experience at AAPS PharmSci 360.